Roivant Sciences Ltd. (ROIV) Financials

ROIV Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 5.3 billion 384.6 million
March 31, 2026 5.7 billion 435.6 million
Dec. 31, 2025 5.2 billion 251.1 million
Sept. 30, 2025 5.1 billion 257.1 million

ROIV Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -263.8 million 83.3 million
March 31, 2026 -165.1 million 77.2 million
Dec. 31, 2025 -191.5 million 105.0 million
Sept. 30, 2025 -193.5 million 81.8 million

ROIV Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 -290.6 million
March 31, 2026 355.7 million
Dec. 31, 2025 -313.7 million
Sept. 30, 2025 -113.5 million

ROIV Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 3.8 billion - 107.2 million
March 31, 2026 4.3 billion - 96.3 million
Dec. 31, 2025 4.5 billion 98.5 million 98.5 million
Sept. 30, 2025 4.4 billion - 98.8 million

ROIV Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 720.8 million
March 31, 2026 812.3 million
Dec. 31, 2025 696.9 million
Sept. 30, 2025 680.9 million

ROIV Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 419000 202.0 million 165.5 million -
March 31, 2026 1.3 million 198.9 million 158.3 million -
Dec. 31, 2025 4.9 million 165.4 million 175.1 million -
Sept. 30, 2025 7.8 million 164.6 million 143.1 million -

ROIV Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.4 million 284000
March 31, 2026 2.5 million 320000
Dec. 31, 2025 2.0 million 700000
Sept. 30, 2025 1.6 million 111000

ROIV Revenue by Segment

Graph available only for paid members. Upgrade to see it.

ROIV

Price: $35.12

52 week price:
12.54
41.88

Earnings Per Share: -0.47 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United Kingdom

Volume: 1.4 million

Market Capitalization: 25.0 billion

Links: